Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · IEX Real-Time Price · USD
6.10
+0.03 (0.49%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Health Catalyst Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Health Catalyst stock have an average target of 12.5, with a low estimate of 8.00 and a high estimate of 16. The average target predicts an increase of 104.92% from the current stock price of 6.10.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HCAT stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Buy | 6 | 6 | 7 | 5 | 6 | 6 |
| Hold | 3 | 3 | 3 | 4 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 13 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $15 → $14 | Buy | Maintains | $15 → $14 | +129.51% | Jun 6, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $11 | Strong Buy | Maintains | $11 | +80.33% | May 21, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $14 → $13 | Buy | Maintains | $14 → $13 | +113.11% | May 10, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $16 | Buy | Reiterates | $16 | +162.30% | Apr 10, 2024 |
| Keybanc | Keybanc | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Apr 10, 2024 |
Financial Forecast
Revenue This Year
314.00M
from 295.94M
Increased by 6.10%
Revenue Next Year
350.59M
from 314.00M
Increased by 11.65%
EPS This Year
0.36
from -2.09
EPS Next Year
0.53
from 0.36
Increased by 47.78%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 325.5M | 369.6M | 417.9M |
| Avg | 314.0M | 350.6M | 396.3M |
| Low | 300.0M | 330.7M | 373.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 10.0% | 17.7% | 19.2% |
| Avg | 6.1% | 11.7% | 13.0% |
| Low | 1.4% | 5.3% | 6.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.50 | 0.67 | 0.95 |
| Avg | 0.36 | 0.53 | 0.76 |
| Low | 0.25 | 0.33 | 0.60 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 88.3% | 79.2% |
| Avg | - | 47.8% | 43.5% |
| Low | - | -6.6% | 13.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.